32 search results for: cytokines

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
Pulmonology
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
expert video

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.

View more
What Are the Key Inflammatory Processes in Patients with COPD?
Pulmonology
What Are the Key Inflammatory Processes in Patients with COPD?
expert video

Dr. Klaus Rabe, MD, PhD, discusses the key inflammatory processes in patients with COPD and their implications for patient care.

View more
The Cycle of Inflammation in Adult Asthma
Pulmonology
The Cycle of Inflammation in Adult Asthma
interactivity

Explore the role of chronic type 2 inflammation in the cycle of exacerbations and worsening lung function in asthma patients.

View more
Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE
Gastroenterology
Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE
expert video

Learn from Prof. Seema Aceves about the interconnectivity of type 2 inflammation and barrier dysfunction in mediating EoE pathophysiology.

View more
Complex EoE Pathophysiology Beyond Esophageal Eosinophilia
Gastroenterology
Complex EoE Pathophysiology Beyond Esophageal Eosinophilia
expert video

Dr. Jonathan Spergel and Prof. Arjan Bredenoord highlight the importance of different immune cells in type 2 inflammation in EoE.

View more
The Pathophysiology of Prurigo Nodularis
Dermatology
The Pathophysiology of Prurigo Nodularis
videoanimation

An infographic exploring the pathophysiology of prurigo nodularis and the role of type 2 inflammation.

View more
The Benefits of Early Intervention in AD: More Than Skin Deep
Congress
9
March
2024
Congress
The Benefits of Early Intervention in AD: More Than Skin Deep

Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.